— Know what they know.
Not Investment Advice

ARE vs VNO vs BXP

161 measures in 16 categories, one definition each, computed from filings and market data.
ARE24.0
Alexandria Real Estate Equities, Inc.
Real Estate · REIT - Office
$41.62 −1.75%$7.3B mkt cap
Score DNA
VNO27.1
Vornado Realty Trust
Real Estate · REIT - Office
$32.93 −0.90%$6.1B mkt cap
Score DNA
BXP36.3
BXP, Inc.
Real Estate · REIT - Office
$59.20 −0.80%$9.5B mkt cap
Score DNA

Price, rebased to 100 three years ago

ARE   VNO   BXP   · weekly adjusted closes
50100150200Jan 24Apr 24Jul 24Oct 24Jan 25Apr 25Jul 25Oct 25Jan 26Apr 26Jul 26Oct 26VNO 164BXP 119ARE 47
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.

Smart money

8 measures
MeasureAREVNOBXP
Insider open-market buys, 180d 9 4 0
Insider $ bought, 180d $1.70M $0.07M —
Congress purchases, 180d 2 0 2
Last Congress purchase 2026-09-25 — 2026-09-11
13F net change in holders +26 +37 +15
ETFs adding shares, 30d 558 287 562
ETFs trimming, 30d 451 204 428
Net ETF funds, 30d +107 +83 +134

Valuation

16 measures
MeasureAREVNOBXP
P/E (TTM) — 90.6x
71st
31.8x
43rd
PEG (P/E ÷ 3-yr EPS CAGR) — — —
Price / sales 2.5x
31st
3.4x
62nd
2.7x
38th
Price / book 0.5x
8th
1.1x
69th
1.8x
85th
Price / tangible book 0.6x
8th
1.3x
69th
2.1x
85th
Price / free cash flow 8.3x
20th
22.7x
80th
26.2x
90th
Price / operating cash flow 5.7x
31st
15.7x
85th
7.4x
46th
Enterprise value $19.6B
92nd
$14.5B
85th
$25.3B
100th
EV / sales 6.6x
23rd
7.9x
69th
7.2x
38th
EV / EBITDA 46.0x
100th
15.7x
67th
13.5x
42nd
EV / EBIT — 37.0x
73rd
27.2x
27th
EV / free cash flow 22.4x
20th
53.7x
70th
70.0x
90th
Earnings yield -12.5%
15th
1.1%
62nd
3.1%
77th
FCF yield 12.1%
85th
4.4%
38th
3.8%
31st
Operating cash flow yield 17.6%
69th
6.4%
15th
13.6%
54th
Graham number (per share) — $15.88
43rd
$36.79
86th

Profitability (TTM)

12 measures
MeasureAREVNOBXP
Gross margin 69.5%
92nd
42.6%
31st
46.8%
38th
EBITDA margin 14.4%
8th
50.7%
38th
53.0%
46th
Operating margin -45.7%
0th
10.9%
15th
35.0%
85th
EBIT margin -28.6%
8th
21.5%
46th
26.4%
69th
Net margin -30.6%
8th
3.7%
62nd
8.4%
69th
NOPAT margin -36.1%
0th
8.5%
15th
35.0%
92nd
FCF margin 29.6%
69th
14.8%
54th
10.3%
31st
Operating cash flow margin 43.3%
62nd
21.4%
15th
36.5%
38th
R&D / revenue 0.0%
0th
0.0%
0th
0.0%
0th
SG&A / revenue 4.4%
15th
8.7%
85th
3.9%
0th
Stock comp / revenue 1.3%
54th
1.4%
62nd
1.3%
38th
Effective tax rate 21.0%
54th
22.0%
100th
0.0%
0th

Returns on capital

11 measures
MeasureAREVNOBXP
ROE (on average equity) -5.5%
15th
1.1%
62nd
5.7%
77th
ROA -2.5%
15th
0.4%
62nd
1.2%
69th
ROIC -3.8%
0th
1.1%
15th
5.9%
100th
ROCE -2.8%
8th
2.6%
54th
3.8%
69th
Return on tangible assets -2.3%
8th
2.5%
54th
3.7%
77th
Cash ROIC (OCF / invested capital) 4.6%
31st
2.8%
15th
6.1%
69th
Gross profitability (GP / assets) 5.9%
62nd
5.0%
38th
6.5%
77th
ROIC, 3-yr average -1.1%
15th
2.2%
69th
2.3%
77th
ROIC, 5-yr average 0.0%
15th
1.4%
54th
2.8%
85th
ROE, 5-yr average -0.0%
31st
2.7%
62nd
6.2%
85th
Incremental ROIC 43.0%
77th
-55.5%
38th
-113.8%
31st

Growth

17 measures
MeasureAREVNOBXP
Revenue growth (TTM YoY) -2.1%
8th
1.4%
38th
1.9%
54th
Revenue growth (QoQ) 18.6%
100th
0.7%
15th
2.7%
69th
Revenue CAGR, 3 yr 2.8%
54th
0.1%
46th
3.2%
62nd
Revenue CAGR, 5 yr 8.2%
92nd
4.1%
54th
4.8%
69th
Gross profit CAGR, 3 yr 2.7%
77th
-5.9%
46th
-6.7%
38th
Operating income CAGR, 3 yr — -13.9%
36th
5.9%
82nd
Net income growth (TTM YoY) — -92.2%
0th
—
Net income CAGR, 3 yr — — -23.6%
33rd
EPS growth (TTM YoY) — -91.7%
0th
—
EPS CAGR, 3 yr — — -24.0%
33rd
EPS CAGR, 5 yr — — -1.6%
67th
FCF growth (TTM YoY) -38.3%
22nd
-80.5%
0th
-48.5%
11th
FCF CAGR, 3 yr -17.3%
40th
-31.1%
10th
-27.2%
30th
Operating cash flow CAGR, 3 yr -6.2%
38th
-19.3%
15th
0.1%
69th
Book value CAGR, 3 yr -9.1%
23rd
1.6%
100th
-5.6%
54th
Dividend CAGR, 3 yr -11.3%
31st
1.4%
92nd
-8.1%
54th
Sustainable growth rate — -2.3%
57th
-4.8%
29th

Margin history & stability

7 measures
MeasureAREVNOBXP
Gross margin, 3-yr average 69.8%
85th
72.4%
92nd
52.1%
38th
Operating margin, 3-yr average 0.4%
0th
13.7%
23rd
34.1%
100th
Net margin, 3-yr average -8.6%
31st
18.9%
100th
4.5%
46th
FCF margin, 3-yr average 39.2%
69th
41.6%
85th
20.1%
54th
Revenue stability (0-1) 0.81
62nd
0.68
54th
0.96
85th
Earnings stability (0-1) 0.81
92nd
0.16
8th
0.26
15th
Margin stability (0-1) 0.98
92nd
0.63
0th
0.88
62nd

Liquidity (latest quarter)

7 measures
MeasureAREVNOBXP
Cash & short-term investments $470.4M
85th
$675.4M
100th
$553.5M
92nd
Net cash (− = net debt) −$12.3B
8th
−$8.4B
15th
−$15.8B
0th
Working capital −$4.1B
0th
$1.3B
100th
−$42.2M
31st
Current ratio 0.11
0th
4.77
92nd
0.94
33rd
Quick ratio 0.11
0th
4.77
92nd
0.94
33rd
Cash ratio (cash + ST investments / current liabilities) 0.10
25th
1.91
100th
0.74
83rd
Defensive interval (days) 51 days
0th
993 days
69th
623 days
54th

Leverage & solvency (latest quarter)

13 measures
MeasureAREVNOBXP
Total debt $12.8B
92nd
$9.1B
85th
$16.4B
100th
Debt / equity 0.82
0th
1.57
69th
3.17
92nd
Net debt / equity 0.79
0th
1.45
54th
3.06
92nd
Debt / assets 37.0%
0th
58.0%
69th
65.0%
92nd
Debt / capital 45.2%
0th
61.0%
69th
76.0%
92nd
Debt / EBITDA 30.10
100th
9.77
75th
8.77
58th
Net debt / EBITDA 29.00
100th
9.04
75th
8.47
58th
Interest coverage (EBIT / interest) −3.4x
0th
1.1x
62nd
1.5x
69th
Cash interest coverage 5.1x
100th
1.1x
23rd
2.1x
54th
Debt payback (years of OCF) 10.0 yrs
46th
23.2 yrs
85th
12.7 yrs
62nd
Liabilities / assets 44.7%
0th
57.1%
31st
69.3%
92nd
IS credit model rating CCC BB- CCC
Implied credit spread (bps) 1,200
77th
550
23rd
1,200
77th

Efficiency

11 measures
MeasureAREVNOBXP
Asset turnover 0.08
0th
0.12
54th
0.14
77th
Fixed asset turnover 0.10
0th
2.74
88th
—
Inventory turnover — — —
Receivables turnover 424.7
100th
2.2
0th
26.6
85th
Days sales outstanding 1 days
0th
166 days
100th
14 days
15th
Days inventory outstanding — — —
Days payables outstanding 590 days
100th
120 days
54th
93 days
23rd
Cash conversion cycle (days) −589 days
0th
46 days
100th
−79 days
31st
Capex / revenue 13.6%
46th
6.6%
31st
26.3%
85th
Capex / depreciation 0.32
38th
0.22
23rd
0.99
77th
Operating expense ratio 70.8%
100th
— —

Cash flow & earnings quality

7 measures
MeasureAREVNOBXP
Operating cash flow / net income — 5.76
71st
4.33
57th
FCF / net income — 3.99
86th
1.22
29th
FCF / operating cash flow 68.5%
62nd
69.2%
69th
28.1%
31st
Capex / operating cash flow 31.5%
38th
30.8%
31st
71.9%
69th
Accruals ratio -6.0%
38th
-2.1%
100th
-3.9%
62nd
Sloan accruals ratio -9.2%
15th
-3.7%
69th
-6.0%
54th
Earnings quality score (0-1) — 1.00
29th
1.00
29th

Dividends & buybacks

9 measures
MeasureAREVNOBXP
Dividend yield 6.9%
77th
2.2%
15th
4.7%
46th
Dividend per share (TTM) $2.88
100th
$0.74
23rd
$2.80
92nd
Payout ratio (dividends / net income) — 299.6%
83rd
183.7%
67th
Dividends / FCF 80.1%
70th
75.2%
60th
151.2%
100th
Dividend growth (YoY) -30.5%
23rd
7.5%
85th
-21.7%
54th
Buyback yield 0.0%
8th
2.2%
100th
0.0%
54th
Shareholder yield (dividends + buybacks) 9.7%
85th
5.5%
23rd
5.8%
38th
Share count change (YoY) 10.7%
85th
-6.9%
0th
0.6%
54th
Buybacks, last 5 years $627.4M
100th
$213.3M
92nd
$4.3M
54th

Scores & forensic checks

15 measures
MeasureAREVNOBXP
IS score 24
15th
27
46th
36
69th
IS profitability 23
23rd
10
8th
32
46th
IS growth 31
31st
21
8th
57
77th
IS value 50
31st
62
85th
47
8th
IS momentum 34
0th
56
46th
86
85th
IS risk (safety) 15
15th
15
15th
15
15th
IS quality 45
38th
53
54th
49
46th
IS balance sheet 26
23rd
39
85th
21
8th
IS earnings quality 70
69th
71
77th
88
92nd
IS cash flow 46
38th
47
54th
37
31st
Piotroski F-score (0-9) 4
15th
6
54th
6
54th
Altman Z-score 0.2
38th
0.5
54th
0.5
62nd
Beneish M-score −4.04
15th
−5.45
0th
5.69
100th
Ohlson O-score −6.94
54th
−7.18
31st
−7.47
8th
IS credit score 15
8th
36
77th
19
15th

Per share

7 measures
MeasureAREVNOBXP
EPS, diluted (TTM) −$4.80
8th
$0.36
62nd
$1.86
100th
Book value per share $82.57
100th
$30.90
62nd
$32.34
69th
Tangible book per share $101.74
100th
$35.19
62nd
$48.61
85th
Revenue per share $15.70
92nd
$9.76
69th
$22.03
100th
FCF per share $4.65
92nd
$1.44
46th
$2.26
69th
Operating cash flow per share $6.79
92nd
$2.09
38th
$8.05
100th
Cash per share $2.50
77th
$3.61
100th
$3.47
92nd

Size (TTM)

8 measures
MeasureAREVNOBXP
Market cap $7.3B
92nd
$6.1B
85th
$9.5B
100th
Revenue $3.0B
92nd
$1.8B
85th
$3.5B
100th
EBITDA $425.6M
38th
$927.5M
92nd
$1.9B
100th
Net income −$904.0M
0th
$67.9M
69th
$296.9M
100th
Free cash flow $876.1M
100th
$270.6M
77th
$360.8M
85th
Total assets $34.6B
100th
$15.6B
85th
$25.2B
92nd
Shareholders' equity $15.6B
100th
$5.8B
92nd
$5.2B
77th
Employees 514
62nd
3,145
100th
826
85th

Price performance

9 measures
MeasureAREVNOBXP
1 day −1.8% −0.9% −0.8%
1 week −8.6% −2.1% +0.3%
1 month −25.1% −5.4% −6.3%
3 months −16.9% −17.1% −12.8%
6 months −14.5% +12.5% +2.0%
Year to date −15.1% −1.6% −12.7%
1 year −45.4% −16.6% −17.4%
3 years, cumulative −54.5% +55.3% +16.0%
5 years, cumulative −74.3% −12.8% −35.4%

Technicals

4 measures
MeasureAREVNOBXP
RSI 14 26.8 37.9 39.5
From 52-week high −47.0% −20.8% −21.0%
From 52-week low +5.6% +34.0% +19.1%
Beta 1.18 1.59 1.05
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms